Enchondroma vs Osteochondroma

Overview & Classification of Cartilage Tumours

Enchondroma and osteochondroma are the two most common benign bone tumours, both arising from cartilage precursors, yet they are fundamentally different in origin, location, biology, and malignant potential. Accurate distinction between them — and from their malignant counterparts — is one of the most important diagnostic exercises in orthopaedic oncology. Cartilage tumours as a group account for approximately 40% of all benign bone tumours.

Feature	Enchondroma	Osteochondroma
Definition	Benign intramedullary hyaline cartilage tumour — cartilage lobules within the medullary canal	Benign cartilage-capped bony exostosis — a bony projection from the cortical surface covered by a cartilaginous cap, with a marrow cavity continuous with the host bone medullary canal
Origin	Failure of normal endochondral ossification — islands of hyaline cartilage remain in the metaphysis/diaphysis instead of being remodelled to bone	Ectopic physeal cartilage that herniates through the cortex and grows as a separate exostosis; shares the same clonal IDH1/IDH2 (enchondroma) or EXT1/EXT2 (osteochondroma) mutations
Location	Short tubular bones of the hand (phalanges, metacarpals) — most common site (60%); also proximal humerus, distal femur, proximal tibia; rare in flat bones; ALWAYS intramedulary; does NOT involve the cortex initially	Metaphysis of long bones — distal femur (most common ~30%), proximal tibia (~20%), proximal humerus (~15%); points AWAY from the nearest joint; cortical surface lesion; does NOT arise in small bones of the hand (if it does, consider subungual exostosis)
Age	Any age; typically detected 2nd–4th decade; often incidental	Childhood and adolescence — grows with the skeleton and typically stops growing at skeletal maturity (physeal closure)
Growth after maturity	Enchondroma should NOT actively grow after skeletal maturity in adults — any growth in an adult = suspicious for malignant transformation to chondrosarcoma	Osteochondroma should STOP growing after physeal closure — continued growth (enlargement of the cartilage cap or expansion of the lesion) in an adult = suspicious for malignant transformation to secondary chondrosarcoma
Malignant potential	Solitary enchondroma: very low (<1% risk of malignant transformation to chondrosarcoma); Ollier`s disease (multiple enchondromatosis): 25–30% risk; Maffucci syndrome: near 100% risk	Solitary osteochondroma: <1% lifetime risk of secondary chondrosarcoma; Hereditary Multiple Exostoses (HME/EXT): 1–5% overall risk (higher for pelvic and shoulder girdle lesions)

Enchondroma — Detailed

Radiographic features: well-defined intramedullary lytic lesion; in small tubular bones of the hand — expansile, lucent, may cause cortical thinning (`expansion without breach`); in long bones — matrix calcification is typical (ring-and-arc pattern — arcuate and stippled calcification within the cartilage lobules on plain X-ray); geographic, well-marginated lytic lesion with sclerotic rim; NO periosteal reaction in a benign enchondroma; NO soft tissue mass; endosteal scalloping may be present but should be <2/3 of the cortical thickness (deeper scalloping raises concern for chondrosarcoma)
MRI features: T1 — low signal; T2/STIR — very high signal (water content of hyaline cartilage); lobulated internal architecture with septa; gadolinium enhancement: peripheral and septal enhancement (ring-and-arc enhancement pattern) — characteristic of cartilage tumours; this lobular enhancement pattern differentiates enchondroma from geographic lytic lesions
Distinguishing enchondroma from chondrosarcoma (the most difficult diagnostic distinction in orthopaedic oncology): the distinction between low-grade chondrosarcoma (Grade 1) and enchondroma is among the hardest in musculoskeletal oncology; plain X-ray features favouring chondrosarcoma — cortical destruction, aggressive periosteal reaction (Codman triangle), deep endosteal scalloping (>2/3 cortical width), soft tissue mass, pain in an adult; MRI features favouring chondrosarcoma — intralesional cysts or necrosis, high T2 signal extending beyond the lesion boundaries, cortical breach; clinical features — new or worsening pain in an adult with a known cartilage lesion is the most important red flag (benign enchondroma in the hand may cause pain due to pathological fracture — but pain in a long-bone enchondroma without fracture should raise concern)

Feature	Favours Enchondroma (Benign)	Favours Chondrosarcoma (Malignant)
Pain	Asymptomatic incidental finding; pain only if pathological fracture (hand phalanx)	Pain in an adult without fracture — the most important clinical red flag; new or worsening pain in a known lesion
Size	<5 cm; small lesions rarely malignant	>5 cm — higher malignancy risk
Endosteal scalloping	<2/3 cortical thickness	>2/3 cortical thickness — strongly suspicious
Periosteal reaction	Absent	Codman triangle or aggressive reaction
Cortex	Intact; possibly thinned	Destroyed / breached
Soft tissue mass	Absent	Present (extracortical extension)
Growth in adult	No interval growth	Progressive enlargement on serial imaging
Location	Distal extremities (hand) — virtually always benign; proximal skeleton (pelvis, shoulder, spine) — higher risk	Proximal/axial skeleton — pelvis, ribs, shoulder girdle; cartilage lesions in these locations more likely malignant

Ollier`s disease (multiple enchondromatosis): non-hereditary condition; multiple enchondromas predominantly on one side of the body; causes limb length discrepancy, deformity, pathological fractures; 25–30% risk of malignant transformation to chondrosarcoma (any of the multiple lesions can transform — not predictable); the diagnosis of malignant transformation requires clinical, radiological, and histological correlation; MRI surveillance of all lesions at regular intervals is recommended in Ollier`s disease
Maffucci syndrome: enchondromatosis + multiple soft tissue haemangiomas (venous malformations); near 100% risk of malignant transformation to chondrosarcoma over lifetime; also increased risk of other malignancies (GI tumours, brain gliomas); surveillance is essential
Management of solitary enchondroma: incidental, asymptomatic, typical radiographic features → observation only; no biopsy required if imaging is characteristic; serial radiographs every 6–12 months initially, then annual; hand phalanx enchondroma presenting with pathological fracture → allow fracture to heal, then curettage and bone grafting if lesion is large or symptomatic; long-bone enchondroma — observation if asymptomatic and benign features; refer to specialist centre if any concerning features

Osteochondroma — Detailed

Radiographic features: bony exostosis arising from the metaphyseal cortex; the cortex and medullary canal of the exostosis are CONTINUOUS with the host bone (this is pathognomonic and distinguishes osteochondroma from parosteal osteosarcoma or other surface lesions); two morphological types: (1) sessile (broad-based) — flat lesion adherent to the cortex; higher risk for symptoms and malignant transformation; (2) pedunculated (stalk with a cartilaginous cap) — more common; less likely to cause impingement; the cartilage cap is not visible on plain X-ray (only the underlying bone is seen); the cap appears as high T2 signal on MRI
Cartilage cap thickness — the key measurement for malignant transformation: the cartilage cap is the critical measurement on MRI; cap thickness <1–2 cm in an adult = benign; cap thickness >2 cm in a skeletally mature adult = suspicious for secondary chondrosarcoma; a cap >3 cm in an adult is highly suspicious; children with active growth may have thicker caps without being malignant (the cap is growing); the key is NOT just the absolute thickness but the combination of thickness, adult skeleton, and associated symptoms (new pain)
Complications of osteochondroma: bursitis (adventitial bursa forms over the cap from friction — presents as a painful swelling adjacent to the exostosis, filled with mucoid fluid; this may mimic a soft tissue tumour on imaging — MRI differentiates); vascular injury (exostosis compresses or erodes adjacent artery — popliteal artery in posterior distal femoral exostosis); nerve compression (common peroneal nerve by proximal fibular exostosis; radial nerve by humeral exostosis); fracture of the stalk (pedunculated osteochondroma); mechanical impingement (two adjacent bones — e.g., proximal tibiofibular osteochondromas causing fibular head impingement on the tibia)
Management: asymptomatic osteochondromas — observation; symptomatic or growing lesions in adults — surgical excision (en bloc excision of the entire exostosis including the perichondrial ring at the base — incomplete excision risks local recurrence); malignant transformation suspected (thick cap >2 cm in adult, new pain) — excise with wide margins; do NOT biopsy a cartilage cap (seeding risk; biopsy results unreliable for distinguishing benign from malignant cartilage)
Hereditary Multiple Exostoses (HME): autosomal dominant; EXT1 (chromosome 8q24) and EXT2 (chromosome 11p11–13) tumour suppressor gene mutations; multiple osteochondromas developing throughout childhood; causes deformity (forearm — Madelung-like deformity from differential radial/ulnar growth; ankle valgus; short stature); 1–5% overall malignant transformation risk (axial/pelvic lesions have highest risk); management — symptomatic lesions excised; surveillance of all lesions

Exam Pearls

Enchondroma: intramedullary; ring-and-arc calcification; hand phalanges most common site; incidental asymptomatic; solitary <1% malignant transformation; pain in adult = red flag for chondrosarcoma
Enchondroma vs chondrosarcoma: most difficult distinction in MSK oncology; endosteal scalloping >2/3 cortical width + pain in adult + cortical breach + soft tissue mass + progressive growth = chondrosarcoma; axial/proximal skeleton location = higher malignancy risk
Ollier`s: multiple enchondromas, one-sided, non-hereditary, 25–30% malignant transformation; Maffucci: enchondromas + venous haemangiomas, ~100% malignant transformation risk
Osteochondroma: cortex and medullary canal continuous with host bone (pathognomonic); metaphyseal; points away from the joint; stops growing at skeletal maturity; sessile and pedunculated types
Cartilage cap thickness on MRI: <1–2 cm in adult = benign; >2 cm in adult = suspicious; >3 cm = highly suspicious for secondary chondrosarcoma; remember children can have thicker benign caps
Do NOT biopsy cartilage cap — seeding risk; results unreliable; if suspicious → excise with wide margins
HME: autosomal dominant; EXT1 (chr 8q24) + EXT2 (chr 11p11–13); multiple exostoses; deformity (forearm, ankle); 1–5% malignant transformation; highest risk for axial/pelvic lesions
Osteochondroma complications: adventitial bursitis (mucoid bursa over cap); vascular erosion (popliteal artery from distal femoral lesion); nerve compression (peroneal nerve from proximal fibular lesion); stalk fracture; impingement between adjacent bones
Excision of osteochondroma: must include perichondrial ring at base — incomplete excision = local recurrence; en bloc excision for symptomatic or suspicious lesions
Key differentiating point: enchondroma — intramedullary; osteochondroma — surface/exophytic with continuous marrow; parosteal osteosarcoma — surface lesion but marrow NOT continuous with host bone (this distinguishes it from osteochondroma)

Enchondroma vs Osteochondroma

References

Share Wiki